(S1 (S (S (NP (NP (NN Overproduction)) (PP (IN of) (NP (JJ human) (NN Myt1) (NN kinase)))) (VP (VBZ induces) (NP (DT a) (NN G2) (NN cell) (NN cycle) (NN delay)) (PP (IN by) (S (VP (VBG interfering) (PP (IN with) (NP (NP (DT the) (JJ intracellular) (NN trafficking)) (PP (IN of) (NP (NN Cdc2-cyclin) (NN B1) (NNS complexes)))))))))) (. .)))
(S1 (S (S (NP (DT The) (NN Myt1) (NN protein) (NN kinase)) (VP (VBZ functions) (S (VP (TO to) (VP (ADVP (RB negatively)) (VB regulate) (NP (NN Cdc2-cyclin) (NN B) (NNS complexes)) (PP (IN by) (S (VP (VBG phosphorylating) (NP (NN Cdc2)) (PP (IN on) (NP (NP (NN threonine) (CD 14)) (CC and) (NP (NN tyrosine) (CD 15)))))))))))) (. .)))
(S1 (S (S (PP (IN Throughout) (NP (NN interphase))) (, ,) (NP (JJ human) (NN Myt1)) (VP (VBZ localizes) (PP (TO to) (NP (NP (DT the) (JJ endoplasmic) (NN reticulum)) (CC and) (NP (NN Golgi) (NN complex)))) (, ,) (SBAR (IN whereas) (S (NP (NN Cdc2-cyclin) (NN B1) (NNS complexes)) (VP (VBP shuttle) (PP (IN between) (NP (NP (DT the) (NN nucleus)) (CC and) (NP (DT the) (NN cytoplasm))))))))) (. .)))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP report) (SBAR (IN that) (S (NP (NP (NN overproduction)) (PP (IN of) (NP (NP (ADJP (CC either) (ADJP (JJ kinase-active)) (CC or) (ADJP (JJ kinase-inactive))) (NNS forms)) (PP (IN of) (NP (NN Myt1)))))) (VP (VP (VBD blocked) (NP (NP (DT the) (JJ nuclear-cytoplasmic) (NN shuttling)) (PP (IN of) (NP (NN cyclin) (NN B1))))) (CC and) (VP (VBD caused) (NP (NNS cells)) (PP (TO to) (NP (NP (NN delay)) (PP (IN in) (NP (NP (DT the) (NN G2) (NN phase)) (PP (IN of) (NP (DT the) (NN cell) (NN cycle))))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ COOH-terminal) (CD 63) (NN amino) (NNS acids)) (PP (IN of) (NP (NN Myt1)))) (VP (VBD were) (VP (VBN identified) (PP (IN as) (NP (DT a) (NN Cdc2-cyclin) (NN B1) (NN interaction) (NN domain)))))) (. .)))
(S1 (S (S (NP (NP (NN Myt1) (NNS mutants)) (VP (VBG lacking) (NP (DT this) (NN domain)))) (ADVP (RB no) (RBR longer)) (VP (VP (VBD bound) (NP (NN cyclin) (NN B1))) (CC and) (VP (VBD did) (RB not) (ADVP (RB efficiently)) (VP (VB phosphorylate) (NP (NN Cdc2-cyclin) (NN B1) (NNS complexes)) (ADVP (FW in) (FW vitro)))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NNS cells)) (VP (VBG overproducing) (NP (NP (JJ mutant) (NNS forms)) (PP (IN of) (NP (NP (NN Myt1)) (VP (VBG lacking) (NP (DT the) (NN interaction) (NN domain)))))))) (VP (VBD exhibited) (NP (NP (JJ normal) (NN trafficking)) (PP (IN of) (NP (NP (NN cyclin) (NN B1)) (CC and) (NP (JJ unperturbed) (NN cell) (NN cycle) (NN progression))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (NP (DT the) (NN docking)) (PP (IN of) (NP (NN Cdc2-cyclin) (NN B1) (NNS complexes))) (PP (TO to) (NP (NP (DT the) (NN COOH) (NN terminus)) (PP (IN of) (NP (NN Myt1)))))) (VP (VBZ facilitates) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NN Cdc2))) (PP (IN by) (NP (NN Myt1))))))) (CC and) (SBAR (IN that) (S (NP (NP (NN overproduction)) (PP (IN of) (NP (NN Myt1)))) (VP (VBZ perturbs) (NP (NN cell) (NN cycle) (NN progression)) (PP (IN by) (S (VP (VBG sequestering) (NP (NN Cdc2-cyclin) (NN B1) (NNS complexes)) (PP (IN in) (NP (DT the) (NN cytoplasm)))))))))))) (. .)))
